SANGAMO THERAPEUTICS, INC Logo

SANGAMO THERAPEUTICS, INC

A clinical-stage genomic medicine company developing therapies for severe diseases.

SGMO | US

Overview

Corporate Details

ISIN(s):
US8006771062
LEI:
Country:
United States of America
Address:
501 CANAL BLVD., 94084 RICHMOND

Description

Sangamo Therapeutics, Inc. is a clinical-stage genomic medicine company focused on translating groundbreaking science into medicines for patients with severe diseases. The company utilizes its proprietary zinc finger (ZFN) technology platform to develop a pipeline of genomic therapies. Its research and development efforts are concentrated on creating potential cures and treatments for a range of conditions, including neurological disorders, autoimmune diseases, and oncology. Sangamo aims to address the underlying genetic causes of diseases where current medical options primarily offer symptom management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 22:10 English 7.9 KB
2025-11-26 22:09 English 7.9 KB
2025-11-26 22:08 English 8.0 KB
2025-11-26 22:07 English 7.9 KB
2025-11-26 22:06 English 8.0 KB
2025-11-26 22:05 English 7.9 KB
2025-11-12 20:34 English 8.0 KB
2025-11-06 14:07
10-Q
English 1.4 MB
2025-11-06 14:05
8-K
English 190.7 KB
2025-10-29 21:08
8-K
English 60.0 KB
2025-10-24 23:00 English 8.0 KB
2025-10-24 23:00 English 7.8 KB
2025-10-24 23:00 English 7.9 KB
2025-10-24 23:00 English 7.9 KB
2025-10-24 23:00 English 7.9 KB

Automate Your Workflow. Get a real-time feed of all SANGAMO THERAPEUTICS, INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANGAMO THERAPEUTICS, INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANGAMO THERAPEUTICS, INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.